We are excited to announce that two AliveDx abstracts are now available publicly in the Abstract Book of the European Congress of Rheumatology (EULAR 2024), an international event that will take place in Vienna, Austria from 12-15 June 2024.
The first abstract provides an overview of the performance of the MosaiQ® AiPlex CTD solution, a CE-marked device intended for the simultaneous detection of 11 autoantibodies associated with autoimmune connective tissue diseases; while the second abstract covers the analytical performance of the MosaiQ AiPlex CTDplus prototype, an investigational device that further expanded the number of featured analytes to 15.
The abstracts are published in an official supplement to the Annals of the Rheumatic Diseases (ARD).
If you wish to read the abstracts, please visit the links below:
- Performance of a novel, fully automated multiplexed immunoassay microarray for the serological detection of eleven autoantibodies commonly found in connective tissue diseases and clinical diagnosis of reactive samples.
P. Ghillani-Dalbin, C. Daubrosse, V. Mercier, D. Bijlsma, E. Lukasik, R. Pasion Galvan, V. Botti, G. Gomez, E. Moreau, M. Hausmann, C. C. Ginocchio, M. Miyara – 2024 AB1514
- Analytical performance of a novel, fully automated multiplexed microarray immunoassay prototype for the simultaneous detection of fifteen autoantibodies associated with connective tissue diseases.
D. Bijlsma, E. Lukasik, M. Hausmann, G. Gomez, C. Fischer, P. Ghillani-Dalbin, M. Miyara, E. Moreau – 2024 AB1518
To learn more, please visit the MosaiQ section of our website.
